0001179110-13-013834.txt : 20130904 0001179110-13-013834.hdr.sgml : 20130904 20130904190957 ACCESSION NUMBER: 0001179110-13-013834 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130830 FILED AS OF DATE: 20130904 DATE AS OF CHANGE: 20130904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOORE NICHOLAS G CENTRAL INDEX KEY: 0001216923 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 131078978 MAIL ADDRESS: STREET 1: 495 EAST JAVA DRIVE CITY: SUNNYVALE STATE: CA ZIP: 94089 4 1 edgar.xml FORM 4 - X0306 4 2013-08-30 0 0000882095 GILEAD SCIENCES INC GILD 0001216923 MOORE NICHOLAS G 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 0 0 0 Common Stock 2013-08-30 4 M 0 130000 20.705 A 130000 I by Trust Common Stock 2013-08-30 4 M 0 21720 19.63 A 151720 I by Trust Common Stock 2013-08-30 4 S 0 146904 60.3981 D 4816 I by Trust Common Stock 2013-08-30 4 S 0 4816 61.0175 D 0 I by Trust Non-Qualified Stock Options (right to buy) 19.63 2013-08-30 4 M 0 21720 0 D 2020-05-11 Common Stock 21720 0 I by Trust Non-Qualified Stock Options (right to buy) 20.705 2013-08-30 4 M 0 130000 0 D 2017-05-09 Common Stock 130000 0 I by Trust The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Options vest quarterly over a period of one year from the date of grant. Options are 100% vested on the date of grant. Sale prices reported for the transactions reported here range from $59.97 to $60.96. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $60.97 to $61.12. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. /s/ Gregg H. Alton by Power of Attorney for Nicholas G. Moore 2013-09-04